Market Executive Summary
The global market for NGS-based RNA-seq was estimated to be worth US$ 1944 million in 2024 and is forecast to a readjusted size of US$ 4071 million by 2031 with a CAGR of 11.3% during the forecast period 2025-2031.
Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market.
The hospitals and clinics segment is expected to register the highest growth due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics.
This report aims to provide a comprehensive presentation of the global market for NGS-based RNA-seq, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of NGS-based RNA-seq by region & country, by Type, and by Application.
The NGS-based RNA-seq market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NGS-based RNA-seq.
Global NGS-based RNA-seq Companies Covered
Illumina, Thermo Fisher Scientific, Pacific Biosciences Of California, Qaigen, F. Hoffmann-La Roche, Agilent Technologies, Oxford Nanopore Technologies, Perkinelmer, Eurofins Scientific, Gatc Biotech, Macrogen
Global NGS-based RNA-seq Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global NGS-based RNA-seq Market, Segment by Type
High-Throughput Sequencing
Third-Generation Sequencing Technology
Global NGS-based RNA-seq Market, Segment by Application
Hospitals and Clinics
Biopharma Companies
Government Agencies
Academic and Research Organizations
Other
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of NGS-based RNA-seq company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of NGS-based RNA-seq in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of NGS-based RNA-seq in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Related Reports:
Global Antisense and RNAi Therapeutics Market Size, Share, Growth Drivers, Trends, Opportunities, Competitive Analysis, and Forecast To 2030
Global siRNA Drug Market Size, Share, Growth Opportunities, Trends, Regional Analysis, and Forecast 2023-2030
Table of Contents
Table of Contents
1 Market Overview
1.1 NGS-based RNA-seq Product Introduction
1.2 Global NGS-based RNA-seq Market Size Forecast (2020-2031)
1.3 NGS-based RNA-seq Market Trends & Drivers
1.3.1 NGS-based RNA-seq Industry Trends
1.3.2 NGS-based RNA-seq Market Drivers & Opportunity
1.3.3 NGS-based RNA-seq Market Challenges
1.3.4 NGS-based RNA-seq Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global NGS-based RNA-seq Players Revenue Ranking (2024)
2.2 Global NGS-based RNA-seq Revenue by Company (2020-2025)
2.3 Key Companies NGS-based RNA-seq Manufacturing Base Distribution and Headquarters
2.4 Key Companies NGS-based RNA-seq Product Offered
2.5 Key Companies Time to Begin Mass Production of NGS-based RNA-seq
2.6 NGS-based RNA-seq Market Competitive Analysis
2.6.1 NGS-based RNA-seq Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by NGS-based RNA-seq Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-seq as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 High-Throughput Sequencing
3.1.2 Third-Generation Sequencing Technology
3.2 Global NGS-based RNA-seq Sales Value by Type
3.2.1 Global NGS-based RNA-seq Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global NGS-based RNA-seq Sales Value, by Type (2020-2031)
3.2.3 Global NGS-based RNA-seq Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Clinics
4.1.2 Biopharma Companies
4.1.3 Government Agencies
4.1.4 Academic and Research Organizations
4.1.5 Other
4.2 Global NGS-based RNA-seq Sales Value by Application
4.2.1 Global NGS-based RNA-seq Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global NGS-based RNA-seq Sales Value, by Application (2020-2031)
4.2.3 Global NGS-based RNA-seq Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global NGS-based RNA-seq Sales Value by Region
5.1.1 Global NGS-based RNA-seq Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global NGS-based RNA-seq Sales Value by Region (2020-2025)
5.1.3 Global NGS-based RNA-seq Sales Value by Region (2026-2031)
5.1.4 Global NGS-based RNA-seq Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America NGS-based RNA-seq Sales Value, 2020-2031
5.2.2 North America NGS-based RNA-seq Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe NGS-based RNA-seq Sales Value, 2020-2031
5.3.2 Europe NGS-based RNA-seq Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific NGS-based RNA-seq Sales Value, 2020-2031
5.4.2 Asia Pacific NGS-based RNA-seq Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America NGS-based RNA-seq Sales Value, 2020-2031
5.5.2 South America NGS-based RNA-seq Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa NGS-based RNA-seq Sales Value, 2020-2031
5.6.2 Middle East & Africa NGS-based RNA-seq Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions NGS-based RNA-seq Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions NGS-based RNA-seq Sales Value, 2020-2031
6.3 United States
6.3.1 United States NGS-based RNA-seq Sales Value, 2020-2031
6.3.2 United States NGS-based RNA-seq Sales Value by Type (%), 2024 VS 2031
6.3.3 United States NGS-based RNA-seq Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe NGS-based RNA-seq Sales Value, 2020-2031
6.4.2 Europe NGS-based RNA-seq Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe NGS-based RNA-seq Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China NGS-based RNA-seq Sales Value, 2020-2031
6.5.2 China NGS-based RNA-seq Sales Value by Type (%), 2024 VS 2031
6.5.3 China NGS-based RNA-seq Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan NGS-based RNA-seq Sales Value, 2020-2031
6.6.2 Japan NGS-based RNA-seq Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan NGS-based RNA-seq Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea NGS-based RNA-seq Sales Value, 2020-2031
6.7.2 South Korea NGS-based RNA-seq Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea NGS-based RNA-seq Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia NGS-based RNA-seq Sales Value, 2020-2031
6.8.2 Southeast Asia NGS-based RNA-seq Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia NGS-based RNA-seq Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India NGS-based RNA-seq Sales Value, 2020-2031
6.9.2 India NGS-based RNA-seq Sales Value by Type (%), 2024 VS 2031
6.9.3 India NGS-based RNA-seq Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Illumina
7.1.1 Illumina Profile
7.1.2 Illumina Main Business
7.1.3 Illumina NGS-based RNA-seq Products, Services and Solutions
7.1.4 Illumina NGS-based RNA-seq Revenue (US$ Million) & (2020-2025)
7.1.5 Illumina Recent Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Profile
7.2.2 Thermo Fisher Scientific Main Business
7.2.3 Thermo Fisher Scientific NGS-based RNA-seq Products, Services and Solutions
7.2.4 Thermo Fisher Scientific NGS-based RNA-seq Revenue (US$ Million) & (2020-2025)
7.2.5 Thermo Fisher Scientific Recent Developments
7.3 Pacific Biosciences Of California
7.3.1 Pacific Biosciences Of California Profile
7.3.2 Pacific Biosciences Of California Main Business
7.3.3 Pacific Biosciences Of California NGS-based RNA-seq Products, Services and Solutions
7.3.4 Pacific Biosciences Of California NGS-based RNA-seq Revenue (US$ Million) & (2020-2025)
7.3.5 Pacific Biosciences Of California Recent Developments
7.4 Qaigen
7.4.1 Qaigen Profile
7.4.2 Qaigen Main Business
7.4.3 Qaigen NGS-based RNA-seq Products, Services and Solutions
7.4.4 Qaigen NGS-based RNA-seq Revenue (US$ Million) & (2020-2025)
7.4.5 Qaigen Recent Developments
7.5 F. Hoffmann-La Roche
7.5.1 F. Hoffmann-La Roche Profile
7.5.2 F. Hoffmann-La Roche Main Business
7.5.3 F. Hoffmann-La Roche NGS-based RNA-seq Products, Services and Solutions
7.5.4 F. Hoffmann-La Roche NGS-based RNA-seq Revenue (US$ Million) & (2020-2025)
7.5.5 F. Hoffmann-La Roche Recent Developments
7.6 Agilent Technologies
7.6.1 Agilent Technologies Profile
7.6.2 Agilent Technologies Main Business
7.6.3 Agilent Technologies NGS-based RNA-seq Products, Services and Solutions
7.6.4 Agilent Technologies NGS-based RNA-seq Revenue (US$ Million) & (2020-2025)
7.6.5 Agilent Technologies Recent Developments
7.7 Oxford Nanopore Technologies
7.7.1 Oxford Nanopore Technologies Profile
7.7.2 Oxford Nanopore Technologies Main Business
7.7.3 Oxford Nanopore Technologies NGS-based RNA-seq Products, Services and Solutions
7.7.4 Oxford Nanopore Technologies NGS-based RNA-seq Revenue (US$ Million) & (2020-2025)
7.7.5 Oxford Nanopore Technologies Recent Developments
7.8 Perkinelmer
7.8.1 Perkinelmer Profile
7.8.2 Perkinelmer Main Business
7.8.3 Perkinelmer NGS-based RNA-seq Products, Services and Solutions
7.8.4 Perkinelmer NGS-based RNA-seq Revenue (US$ Million) & (2020-2025)
7.8.5 Perkinelmer Recent Developments
7.9 Eurofins Scientific
7.9.1 Eurofins Scientific Profile
7.9.2 Eurofins Scientific Main Business
7.9.3 Eurofins Scientific NGS-based RNA-seq Products, Services and Solutions
7.9.4 Eurofins Scientific NGS-based RNA-seq Revenue (US$ Million) & (2020-2025)
7.9.5 Eurofins Scientific Recent Developments
7.10 Gatc Biotech
7.10.1 Gatc Biotech Profile
7.10.2 Gatc Biotech Main Business
7.10.3 Gatc Biotech NGS-based RNA-seq Products, Services and Solutions
7.10.4 Gatc Biotech NGS-based RNA-seq Revenue (US$ Million) & (2020-2025)
7.10.5 Gatc Biotech Recent Developments
7.11 Macrogen
7.11.1 Macrogen Profile
7.11.2 Macrogen Main Business
7.11.3 Macrogen NGS-based RNA-seq Products, Services and Solutions
7.11.4 Macrogen NGS-based RNA-seq Revenue (US$ Million) & (2020-2025)
7.11.5 Macrogen Recent Developments
8 Industry Chain Analysis
8.1 NGS-based RNA-seq Industrial Chain
8.2 NGS-based RNA-seq Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 NGS-based RNA-seq Sales Model
8.5.2 Sales Channel
8.5.3 NGS-based RNA-seq Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Figures
Table of Figures
List of Tables
Table 1. NGS-based RNA-seq Market Trends
Table 2. NGS-based RNA-seq Market Drivers & Opportunity
Table 3. NGS-based RNA-seq Market Challenges
Table 4. NGS-based RNA-seq Market Restraints
Table 5. Global NGS-based RNA-seq Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global NGS-based RNA-seq Revenue Market Share by Company (2020-2025)
Table 7. Key Companies NGS-based RNA-seq Manufacturing Base Distribution and Headquarters
Table 8. Key Companies NGS-based RNA-seq Product Type
Table 9. Key Companies Time to Begin Mass Production of NGS-based RNA-seq
Table 10. Global NGS-based RNA-seq Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-seq as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global NGS-based RNA-seq Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global NGS-based RNA-seq Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global NGS-based RNA-seq Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global NGS-based RNA-seq Sales Market Share in Value by Type (2020-2025)
Table 17. Global NGS-based RNA-seq Sales Market Share in Value by Type (2026-2031)
Table 18. Global NGS-based RNA-seq Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global NGS-based RNA-seq Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global NGS-based RNA-seq Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global NGS-based RNA-seq Sales Market Share in Value by Application (2020-2025)
Table 22. Global NGS-based RNA-seq Sales Market Share in Value by Application (2026-2031)
Table 23. Global NGS-based RNA-seq Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global NGS-based RNA-seq Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global NGS-based RNA-seq Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global NGS-based RNA-seq Sales Value by Region (2020-2025) & (%)
Table 27. Global NGS-based RNA-seq Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions NGS-based RNA-seq Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions NGS-based RNA-seq Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions NGS-based RNA-seq Sales Value, (2026-2031) & (US$ Million)
Table 31. Illumina Basic Information List
Table 32. Illumina Description and Business Overview
Table 33. Illumina NGS-based RNA-seq Products, Services and Solutions
Table 34. Revenue (US$ Million) in NGS-based RNA-seq Business of Illumina (2020-2025)
Table 35. Illumina Recent Developments
Table 36. Thermo Fisher Scientific Basic Information List
Table 37. Thermo Fisher Scientific Description and Business Overview
Table 38. Thermo Fisher Scientific NGS-based RNA-seq Products, Services and Solutions
Table 39. Revenue (US$ Million) in NGS-based RNA-seq Business of Thermo Fisher Scientific (2020-2025)
Table 40. Thermo Fisher Scientific Recent Developments
Table 41. Pacific Biosciences Of California Basic Information List
Table 42. Pacific Biosciences Of California Description and Business Overview
Table 43. Pacific Biosciences Of California NGS-based RNA-seq Products, Services and Solutions
Table 44. Revenue (US$ Million) in NGS-based RNA-seq Business of Pacific Biosciences Of California (2020-2025)
Table 45. Pacific Biosciences Of California Recent Developments
Table 46. Qaigen Basic Information List
Table 47. Qaigen Description and Business Overview
Table 48. Qaigen NGS-based RNA-seq Products, Services and Solutions
Table 49. Revenue (US$ Million) in NGS-based RNA-seq Business of Qaigen (2020-2025)
Table 50. Qaigen Recent Developments
Table 51. F. Hoffmann-La Roche Basic Information List
Table 52. F. Hoffmann-La Roche Description and Business Overview
Table 53. F. Hoffmann-La Roche NGS-based RNA-seq Products, Services and Solutions
Table 54. Revenue (US$ Million) in NGS-based RNA-seq Business of F. Hoffmann-La Roche (2020-2025)
Table 55. F. Hoffmann-La Roche Recent Developments
Table 56. Agilent Technologies Basic Information List
Table 57. Agilent Technologies Description and Business Overview
Table 58. Agilent Technologies NGS-based RNA-seq Products, Services and Solutions
Table 59. Revenue (US$ Million) in NGS-based RNA-seq Business of Agilent Technologies (2020-2025)
Table 60. Agilent Technologies Recent Developments
Table 61. Oxford Nanopore Technologies Basic Information List
Table 62. Oxford Nanopore Technologies Description and Business Overview
Table 63. Oxford Nanopore Technologies NGS-based RNA-seq Products, Services and Solutions
Table 64. Revenue (US$ Million) in NGS-based RNA-seq Business of Oxford Nanopore Technologies (2020-2025)
Table 65. Oxford Nanopore Technologies Recent Developments
Table 66. Perkinelmer Basic Information List
Table 67. Perkinelmer Description and Business Overview
Table 68. Perkinelmer NGS-based RNA-seq Products, Services and Solutions
Table 69. Revenue (US$ Million) in NGS-based RNA-seq Business of Perkinelmer (2020-2025)
Table 70. Perkinelmer Recent Developments
Table 71. Eurofins Scientific Basic Information List
Table 72. Eurofins Scientific Description and Business Overview
Table 73. Eurofins Scientific NGS-based RNA-seq Products, Services and Solutions
Table 74. Revenue (US$ Million) in NGS-based RNA-seq Business of Eurofins Scientific (2020-2025)
Table 75. Eurofins Scientific Recent Developments
Table 76. Gatc Biotech Basic Information List
Table 77. Gatc Biotech Description and Business Overview
Table 78. Gatc Biotech NGS-based RNA-seq Products, Services and Solutions
Table 79. Revenue (US$ Million) in NGS-based RNA-seq Business of Gatc Biotech (2020-2025)
Table 80. Gatc Biotech Recent Developments
Table 81. Macrogen Basic Information List
Table 82. Macrogen Description and Business Overview
Table 83. Macrogen NGS-based RNA-seq Products, Services and Solutions
Table 84. Revenue (US$ Million) in NGS-based RNA-seq Business of Macrogen (2020-2025)
Table 85. Macrogen Recent Developments
Table 86. Key Raw Materials Lists
Table 87. Raw Materials Key Suppliers Lists
Table 88. NGS-based RNA-seq Downstream Customers
Table 89. NGS-based RNA-seq Distributors List
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. NGS-based RNA-seq Product Picture
Figure 2. Global NGS-based RNA-seq Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global NGS-based RNA-seq Sales Value (2020-2031) & (US$ Million)
Figure 4. NGS-based RNA-seq Report Years Considered
Figure 5. Global NGS-based RNA-seq Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by NGS-based RNA-seq Revenue in 2024
Figure 7. NGS-based RNA-seq Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. High-Throughput Sequencing Picture
Figure 9. Third-Generation Sequencing Technology Picture
Figure 10. Global NGS-based RNA-seq Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 11. Global NGS-based RNA-seq Sales Value Market Share by Type, 2024 & 2031
Figure 12. Product Picture of Hospitals and Clinics
Figure 13. Product Picture of Biopharma Companies
Figure 14. Product Picture of Government Agencies
Figure 15. Product Picture of Academic and Research Organizations
Figure 16. Product Picture of Other
Figure 17. Global NGS-based RNA-seq Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 18. Global NGS-based RNA-seq Sales Value Market Share by Application, 2024 & 2031
Figure 19. North America NGS-based RNA-seq Sales Value (2020-2031) & (US$ Million)
Figure 20. North America NGS-based RNA-seq Sales Value by Country (%), 2024 VS 2031
Figure 21. Europe NGS-based RNA-seq Sales Value, (2020-2031) & (US$ Million)
Figure 22. Europe NGS-based RNA-seq Sales Value by Country (%), 2024 VS 2031
Figure 23. Asia Pacific NGS-based RNA-seq Sales Value, (2020-2031) & (US$ Million)
Figure 24. Asia Pacific NGS-based RNA-seq Sales Value by Region (%), 2024 VS 2031
Figure 25. South America NGS-based RNA-seq Sales Value, (2020-2031) & (US$ Million)
Figure 26. South America NGS-based RNA-seq Sales Value by Country (%), 2024 VS 2031
Figure 27. Middle East & Africa NGS-based RNA-seq Sales Value, (2020-2031) & (US$ Million)
Figure 28. Middle East & Africa NGS-based RNA-seq Sales Value by Country (%), 2024 VS 2031
Figure 29. Key Countries/Regions NGS-based RNA-seq Sales Value (%), (2020-2031)
Figure 30. United States NGS-based RNA-seq Sales Value, (2020-2031) & (US$ Million)
Figure 31. United States NGS-based RNA-seq Sales Value by Type (%), 2024 VS 2031
Figure 32. United States NGS-based RNA-seq Sales Value by Application (%), 2024 VS 2031
Figure 33. Europe NGS-based RNA-seq Sales Value, (2020-2031) & (US$ Million)
Figure 34. Europe NGS-based RNA-seq Sales Value by Type (%), 2024 VS 2031
Figure 35. Europe NGS-based RNA-seq Sales Value by Application (%), 2024 VS 2031
Figure 36. China NGS-based RNA-seq Sales Value, (2020-2031) & (US$ Million)
Figure 37. China NGS-based RNA-seq Sales Value by Type (%), 2024 VS 2031
Figure 38. China NGS-based RNA-seq Sales Value by Application (%), 2024 VS 2031
Figure 39. Japan NGS-based RNA-seq Sales Value, (2020-2031) & (US$ Million)
Figure 40. Japan NGS-based RNA-seq Sales Value by Type (%), 2024 VS 2031
Figure 41. Japan NGS-based RNA-seq Sales Value by Application (%), 2024 VS 2031
Figure 42. South Korea NGS-based RNA-seq Sales Value, (2020-2031) & (US$ Million)
Figure 43. South Korea NGS-based RNA-seq Sales Value by Type (%), 2024 VS 2031
Figure 44. South Korea NGS-based RNA-seq Sales Value by Application (%), 2024 VS 2031
Figure 45. Southeast Asia NGS-based RNA-seq Sales Value, (2020-2031) & (US$ Million)
Figure 46. Southeast Asia NGS-based RNA-seq Sales Value by Type (%), 2024 VS 2031
Figure 47. Southeast Asia NGS-based RNA-seq Sales Value by Application (%), 2024 VS 2031
Figure 48. India NGS-based RNA-seq Sales Value, (2020-2031) & (US$ Million)
Figure 49. India NGS-based RNA-seq Sales Value by Type (%), 2024 VS 2031
Figure 50. India NGS-based RNA-seq Sales Value by Application (%), 2024 VS 2031
Figure 51. NGS-based RNA-seq Industrial Chain
Figure 52. NGS-based RNA-seq Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
